Popular drugs for diabetes and weight loss could have an unexpected side effect. Glucagon-like peptide 1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked ...

Diabetes silently damages eyes by weakening retinal blood vessels, leading to vision loss through conditions like retinopathy ...

Headlines warning about “Ozempic blindness” may be frightening to the millions of people taking a GLP-1 drug to treat Type 2 diabetes or for weight loss. It's not an official diagnosis, but an ...

Retina Blood Vessel Damage: Diabetes affects not only the heart, kidneys, liver, and nerves, but also the eyes. Many people ...

Dec 12 (Reuters) - Vision loss likely related to diabetes in the United States increased by 20 percent over less than a decade, according to a U.S. study - a matter of concern as diabetes rates ...

Blockbuster GLP-1 medications like Ozempic and Mounjaro might sharpen your figure, but they could also cloud your vision in the process. A review published in JAMA Ophthalmology uncovered at least ...

Wills Eye Hospital in Philadelphia and other sites around the region will host free eye screenings for Diabetes Day.

The percentage of adults with diabetes who self-reported vision problems decreased from 26 percent in 1997 to 18.6 percent in 2010, according to a Center for Disease Control report. The actual number ...

The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare eye condition known as NAION (non-arteritic anterior ischemic optic ...

Ozempic blindness isn’t a real diagnosis. It’s a nickname used to describe sudden vision loss that may be linked to the weight loss drugs semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, ...

Share on Pinterest Researchers believe that high doses of semaglutide may reduce blood flow to the optic nerve, which could lead to eye stroke. Maria Korneeva/Getty Images A new study has found that ...